1st patient dosed in Phase 2 trial of Parkinson’s therapy VTX3232
The first patient with early Parkinson’s disease has been dosed in Ventyx Biosciences‘ Phase 2a clinical trial of…
Articles by Patricia Inácio, PhD
Regeneron joins data program for LEARNS digital biomarkers trial
Regeneron has joined the data syndication program for Koneksa‘s LEARNS study that’s assessing the potential of digital biomarkers…
Blood DNA methylation profiles may rate Parkinson’s dementia risk
Understanding and identifying epigenetic changes — those that affect gene activity without altering a gene’s DNA sequence — in blood…
Phase 1 trial of investigational therapy ALX-001 doses first patient
A Phase 1 trial of ALX-001, an investigational therapy for neurodegenerative conditions, has dosed the first patient with Parkinson’s…
Technology for protein fingerprints may aid with early diagnosis
Inoviq’s Neuro-Net technology can aid in diagnosing Parkinson’s disease at early stages, with it having effectively isolated and…
5 scientists win 2024 SPARK NS awards for Parkinson’s research
The nonprofit SPARK NS has announced the five recipients of the 2024 SPARK NS Parkinson’s Disease Translational Research…
FDA OKs Phase 2 clinical trial design of bezisterim for Parkinson’s
The U.S. Food and Drug Administration (FDA) has agreed on the design of the upcoming Phase 2 SUNRISE-PD clinical trial…
Parkinson’s Foundation awards more than $1M in grants
The Parkinson’s Foundation has awarded more than $1 million in 92 community-based grants across 40 states in the U.S. to…
Seaweed polyphenols may protect nerve cells, ease symptoms
Compounds called polyphenols in the Ecklonia cava seaweed eased motor and nonmotor symptoms in a mouse model of Parkinson’s…
MJFF challenge sets new goal after Pacific rowers raise $28M
From Monterey Bay in California to Hanalei Bay in Kauai, Hawaii, Team HPP (Human Powered Potential) has rowed 2,800 miles…